Acumen Pharmaceuticals, Inc. (ABOS) NASDAQ
2.81
+0.08(+2.93%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.81
+0.08(+2.93%)
Currency In USD
| Market Cap | 127.79M |
| Enterprise Value | 105.11M |
| P/E Ratio | -1.4 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.42 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.25 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.99 |
| Return On Equity | -1.11 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -184,000 |
| EBITDA | -123.83M |
| Net Income | -121.34M |
| Diluted EPS | -2 |
| Total Cash | 116.87M |
| Total Cash/Share | 1.93 |
| Total Debt | 31.31M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 4.07 |
| Book Value Per Share | 1.16 |
| 52-Week Change | 175.49 |
| 52-Week High | 3.6 |
| 52-Week Low | 0.96 |
| Moving Average 50 Days | 2.79 |
| Moving Average 200 Days | 2.03 |
| Average Volume | 904,186 |
| Shares Outstanding | 60.57M |
| % Held by Institutions | 58.87 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |